NCT07589374

Brief Summary

This study aims to investigate how metabolic health is related to arterial stiffness and daily blood pressure patterns. High blood pressure is one of the leading causes of heart disease worldwide, but cardiovascular risk is not determined only by average blood pressure values. Changes in blood vessel structure and metabolic function also play an important role in the development of cardiovascular disease. Arterial stiffness reflects how flexible or rigid the arteries are. It can be measured using carotid-femoral pulse wave velocity (cf-PWV), which is considered a reliable and widely used method to assess vascular health. Increased arterial stiffness is associated with aging and higher cardiovascular risk. At the same time, metabolic factors such as insulin resistance and central obesity are strongly linked to vascular damage. The triglyceride-glucose (TyG) index is a simple measure derived from routine blood tests and has been shown to reflect insulin resistance. Additional derived indices that combine TyG with body measurements (such as waist circumference and body mass index) may provide an even more comprehensive evaluation of metabolic risk. Another important aspect of cardiovascular regulation is how blood pressure changes throughout the day. Blood pressure naturally rises in the morning after waking, a phenomenon known as the morning blood pressure surge. When this increase is excessive, it has been associated with a higher risk of cardiovascular events such as stroke and heart attack. This study will evaluate the relationship between metabolic indices, arterial stiffness, and morning blood pressure patterns in adults undergoing ambulatory blood pressure monitoring as part of routine clinical care. The study will include both previously collected data and new participants evaluated using standardized methods. No additional interventions will be performed, and all data will be collected as part of routine clinical evaluation. The results of this study may help improve cardiovascular risk assessment by integrating simple metabolic markers with vascular measurements and daily blood pressure behavior, potentially allowing earlier identification of individuals at higher risk.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
24mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

May 22, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

May 2, 2026

Last Update Submit

May 19, 2026

Conditions

Keywords

Arterial stiffnessPulse wave velocityTriglyceride-glucose indexInsulin resistanceAmbulatory blood pressure monitoringMorning blood pressure surgeBlood pressure variabilityCardiovascular risk

Outcome Measures

Primary Outcomes (1)

  • Carotid-femoral pulse wave velocity (cf-PWV)

    Carotid-femoral pulse wave velocity (cf-PWV) will be measured as a marker of arterial stiffness using a validated non-invasive device under standardized conditions. The association between cf-PWV and the triglyceride-glucose (TyG) index will be evaluated.

    Baseline

Secondary Outcomes (4)

  • Morning systolic blood pressure

    Average systolic blood pressure during the first two hours after awakening, obtained from 24-hour ambulatory blood pressure monitoring (ABPM).

  • Morning diastolic blood pressure

    Average diastolic blood pressure during the first two hours after awakening, obtained from ABPM.

  • Sleep-through morning blood pressure surge

    Difference between morning systolic blood pressure and the lowest nocturnal systolic blood pressure value.

  • Prewaking morning blood pressure surge

    Difference between morning systolic blood pressure and the average systolic blood pressure during the two hours preceding awakening.

Study Arms (2)

Normotensive participants

Adults with normal 24-hour blood pressure based on ABPM (\< 130/80 mmHg)

Untreated hypertensive participants

Adults with elevated 24-hour blood pressure (≥130/80 mmHg) not receiving antihypertensive treatment.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adults aged 18 to 65 years referred for ambulatory blood pressure monitoring (ABPM) as part of routine clinical evaluation at a specialized cardiovascular center. Participants will include both normotensive individuals and untreated hypertensive individuals, classified based on 24-hour ABPM measurements. The study will include both previously collected data and prospectively recruited participants evaluated using standardized protocols.

You may qualify if:

  • Adults aged 18 to 65 years;
  • Both sexes;
  • Referred for ambulatory blood pressure monitoring (ABPM) as part of routine clinical evaluation;
  • Not receiving antihypertensive medication at the time of assessment;
  • Availability of valid 24-hour ABPM data;
  • Availability of carotid-femoral pulse wave velocity (cf-PWV) measurement;
  • Availability of fasting laboratory data, including glucose and triglycerides, for calculation of the triglyceride-glucose (TyG) index;
  • Ability and willingness to provide written informed consent (for prospectively recruited participants).

You may not qualify if:

  • Use of antihypertensive medication at the time of evaluation;
  • Cardiac arrhythmias that may interfere with accurate blood pressure or pulse wave velocity measurements;
  • Invalid or poor-quality ambulatory blood pressure monitoring (ABPM) recordings;
  • Inability to obtain reliable carotid-femoral pulse wave velocity (cf-PWV) measurements;
  • Presence of severe vascular disease or conditions affecting arterial waveform assessment;
  • Missing essential clinical, laboratory, or hemodynamic data required for the primary analysis;
  • Pregnancy;
  • Refusal or inability to provide informed consent (for prospectively recruited participants).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medicine School of SĂ£o JosĂ© do Rio Preto

SĂ£o JosĂ© do Rio Preto, SĂ£o Paulo, 15090-000, Brazil

Location

Related Publications (27)

  • Chirinos JA, Segers P, Hughes T, Townsend R. Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 Sep 3;74(9):1237-1263. doi: 10.1016/j.jacc.2019.07.012.

  • Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T; Artery Society; European Society of Hypertension Working Group on Vascular Structure and Function; European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012 Mar;30(3):445-8. doi: 10.1097/HJH.0b013e32834fa8b0.

  • Parati G, Stergiou G, O'Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014 Jul;32(7):1359-66. doi: 10.1097/HJH.0000000000000221.

  • O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013 Sep;31(9):1731-68. doi: 10.1097/HJH.0b013e328363e964.

  • Muntner P, Shimbo D, Carey RM, Charleston JB, Gaillard T, Misra S, Myers MG, Ogedegbe G, Schwartz JE, Townsend RR, Urbina EM, Viera AJ, White WB, Wright JT Jr. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association. Hypertension. 2019 May;73(5):e35-e66. doi: 10.1161/HYP.0000000000000087.

  • Johnson AW, Hissen SL, Macefield VG, Brown R, Taylor CE. Magnitude of Morning Surge in Blood Pressure Is Associated with Sympathetic but Not Cardiac Baroreflex Sensitivity. Front Neurosci. 2016 Sep 8;10:412. doi: 10.3389/fnins.2016.00412. eCollection 2016.

  • Bilo G, Grillo A, Guida V, Parati G. Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects. Integr Blood Press Control. 2018 May 24;11:47-56. doi: 10.2147/IBPC.S130277. eCollection 2018.

  • Renna NF, Ramirez JM, Murua M, Bernasconi PA, Repetto JM, Verdugo RA, Farez BG, Miatello RM, Diez ER. Morning blood pressure surge as a predictor of cardiovascular events in patients with hypertension. Blood Press Monit. 2023 Jun 1;28(3):149-157. doi: 10.1097/MBP.0000000000000641. Epub 2023 Apr 13.

  • Booth JN 3rd, Jaeger BC, Huang L, Abdalla M, Sims M, Butler M, Muntner P, Shimbo D. Morning Blood Pressure Surge and Cardiovascular Disease Events and All-Cause Mortality in Blacks: The Jackson Heart Study. Hypertension. 2020 Mar;75(3):835-843. doi: 10.1161/HYPERTENSIONAHA.119.14233. Epub 2020 Feb 3.

  • Bombelli M, Fodri D, Toso E, Macchiarulo M, Cairo M, Facchetti R, Dell'Oro R, Grassi G, Mancia G. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension. 2014 Nov;64(5):943-50. doi: 10.1161/HYPERTENSIONAHA.114.03675. Epub 2014 Aug 25.

  • Kario K. Morning surge in blood pressure and cardiovascular risk: evidence and perspectives. Hypertension. 2010 Nov;56(5):765-73. doi: 10.1161/HYPERTENSIONAHA.110.157149. Epub 2010 Oct 11. No abstract available.

  • Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003 Mar 18;107(10):1401-6. doi: 10.1161/01.cir.0000056521.67546.aa.

  • Wakabayashi I, Daimon T. The "cardiometabolic index" as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta. 2015 Jan 1;438:274-8. doi: 10.1016/j.cca.2014.08.042. Epub 2014 Sep 6.

  • Liu H, Meng C, Wang Z, Liu C, Yu C, Li Z. Association of Novel Insulin Resistance Indices with Blood Pressure in New-Onset Hypertension and Elevated Blood Pressure Individuals: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2023 Dec 5;16:3953-3965. doi: 10.2147/DMSO.S432049. eCollection 2023.

  • Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, Maeda Y, McDougall A, Peterson CM, Ravussin E, Heymsfield SB. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring). 2013 Nov;21(11):2264-71. doi: 10.1002/oby.20408. Epub 2013 Jun 11.

  • Xuan W, Liu D, Zhong J, Luo H, Zhang X. Impacts of Triglyceride Glucose-Waist to Height Ratio on Diabetes Incidence: A Secondary Analysis of A Population-Based Longitudinal Data. Front Endocrinol (Lausanne). 2022 Jul 22;13:949831. doi: 10.3389/fendo.2022.949831. eCollection 2022.

  • Song K, Xu Y, Wu S, Zhang X, Wang Y, Pan S. Research status of triglyceride glucose-body mass index (TyG-BMI index). Front Cardiovasc Med. 2025 Jul 18;12:1597112. doi: 10.3389/fcvm.2025.1597112. eCollection 2025.

  • Cui H, Liu Q, Wu Y, Cao L. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022 Feb 10;21(1):22. doi: 10.1186/s12933-022-01456-1.

  • Avagimyan A, Pogosova N, Fogacci F, Aghajanova E, Djndoyan Z, Patoulias D, Sasso LL, Bernardi M, Faggiano A, Mohammadifard N, Neglia D, Carugo S, Cicero A, Rizzo M, Biondi-Zoccai G, De Caterina R, Sarrafzadegan N. Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. Int J Cardiol. 2025 Jan 1;418:132663. doi: 10.1016/j.ijcard.2024.132663. Epub 2024 Oct 18.

  • Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008 Dec;6(4):299-304. doi: 10.1089/met.2008.0034.

  • Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004 Feb;43(2):176-81. doi: 10.1161/01.HYP.0000111829.46090.92. Epub 2003 Dec 29.

  • Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res. 2012 Jan;35(1):4-16. doi: 10.1038/hr.2011.173. Epub 2011 Nov 3.

  • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27. doi: 10.1016/j.jacc.2009.10.061.

  • Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, Najjar SS, Nichols WW, Urbina EM, Weber T; American Heart Association Council on Hypertension. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension. 2015 Sep;66(3):698-722. doi: 10.1161/HYP.0000000000000033. Epub 2015 Jul 9. No abstract available.

  • Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997 Jul 1;96(1):308-15. doi: 10.1161/01.cir.96.1.308.

  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002 Dec 14;360(9349):1903-13. doi: 10.1016/s0140-6736(02)11911-8.

  • Arima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens. 2011 Dec;29 Suppl 1:S3-7. doi: 10.1097/01.hjh.0000410246.59221.b1.

MeSH Terms

Conditions

HypertensionMetabolic SyndromeInsulin Resistance

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Jose F VILELA-MARTIN, PhD

    Medicine School of SĂ£o JosĂ© do Rio Preto - SP - Brazil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marco A VIEIRA-da-SILVA, MSc

CONTACT

Marco A de Almeida, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

May 2, 2026

First Posted

May 15, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2028

Last Updated

May 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will be available upon reasonable request to the corresponding author, following publication of the study results. Data sharing will be subject to approval by the responsible ethics committee and compliance with applicable data protection regulations. De-identified data may be shared for research purposes only, under a data use agreement to ensure participant confidentiality.

Locations